Document Detail

Fenofibrate Inhibits Endothelin-1 Expression by Peroxisome Proliferator-Activated Receptor α-Dependent and Independent Mechanisms in Human Endothelial Cells.
MedLine Citation:
PMID:  23329136     Owner:  NLM     Status:  Publisher    
OBJECTIVE: Dyslipidemia contributes to endothelial dysfunction in type 2 diabetes mellitus. Fenofibrate (FF), a ligand of the peroxisome proliferator-activated receptor-α (PPARα), has beneficial effects on microvascular complications. FF may act on the endothelium by regulating vasoactive factors, including endothelin-1 (ET-1). In vitro, FF decreases ET-1 expression in human microvascular endothelial human microvascular endothelial cell line cells. We investigated the molecular mechanisms involved in the effect of FF treatment on plasma levels of ET-1 in type 2 diabetes mellitus patients. METHODS AND RESULTS: FF impaired the capacity of transforming growth factor-β to induce ET-1 gene expression. PPARα activation by FF increased expression of the transcriptional repressor Krüppel-like factor 11 and its binding to the ET-1 gene promoter. Knockdown of Krüppel-like factor 11 expression potentiated basal and transforming growth factor-β-stimulated ET-1 expression, suggesting that Krüppel-like factor 11 downregulates ET-1 expression. FF, in a PPARα-independent manner, and insulin enhanced glycogen synthase kinase-3β phosphorylation thus reducing glycogen synthase kinase-3 activity that contributes to the FF-mediated reduction of ET-1 gene expression. In type 2 diabetes mellitus, improvement of flow-mediated dilatation of the brachial artery by FF was associated with a decrease in plasma ET-1. CONCLUSIONS: FF decreases ET-1 expression by a PPARα-dependent mechanism, via transcriptional induction of the Krüppel-like factor 11 repressor and by PPARα-independent actions via inhibition of glycogen synthase kinase-3 activity.
Corine Glineur; Barbara Gross; Bernadette Neve; Corinne Rommens; Gerard T Chew; Françoise Martin-Nizard; Fernando Rodríguez-Pascual; Santiago Lamas; Gerald F Watts; Bart Staels
Related Documents :
25031316 - Endometrial cxcl13 expression is cycle regulated in humans and aberrantly expressed in ...
23862616 - The role of transcription factors in the formation of an arrhythmogenic substrate in co...
24924386 - Evaluation of calibration curve-based approaches to predict clinical inducers and non-i...
24723426 - The human long noncoding rna, lnc-il7r, regulates inflammatory response.
1423646 - Reduced binding activity of transcription factor nf-kappa b accounts for mhc class i re...
12139976 - Interindividual variation and organ-specific patterns of glutathione s-transferase alph...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-17
Journal Detail:
Title:  Arteriosclerosis, thrombosis, and vascular biology     Volume:  -     ISSN:  1524-4636     ISO Abbreviation:  Arterioscler. Thromb. Vasc. Biol.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9505803     Medline TA:  Arterioscler Thromb Vasc Biol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Université Lille Nord de France, Lille, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Chronic Kidney Disease, Plasma Lipoproteins, and Coronary Artery Calcium Incidence The Multi-Ethnic ...
Next Document:  Multiple Biomarkers for the Prediction of Ischemic Stroke: The PRIME Study.